Heslop, Helen E.,Straathof, Karin,Gottschalk, Stephen M.G.,Rooney, Cliona M.,Louis, Chrystal U.,Brenner, Malcolm K.
申请号：
AU2016273880
公开号：
AU2016273880A1
申请日:
2016.12.14
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2016273880A120170105.pdf#####ABSTRACT The present invention concerns methods and compositions for treatment of locoregional nasopharyngeal carcinoma utilizing EBV-specific T cells. In specific embodiments, locoregional solid tumors are treated with cytotoxic T lymphocytes specific for at least one EBV antigen, such as LMP2, LMP1, and/or EBNA1, for example.
